Home » Newsletters » BioWorld Science

BioWorld Science

April 2, 2003

View Archived Issues

SPL-7013 gel prevents SIV transmission in SIV-infected macaques

Fidarestat prevents retinal oxidative stress and overexpression of VEGF

FDA approves carvedilol for reducing risk of myocardial infarction

Novel IGF-1R inhibitors in early development at Amgen

AstraZeneca presents N-type calcium channel antagonists as potential analgesic agents

H+/K+-ATPase inhibitors and their use described by AstraZeneca researchers

Taisho describes new antibacterial erythromycins

PDE4 inhibitors described by Merck Frosst for asthma and other uses

Nonimmunosuppressive rapamycins for neurodegeneration, cancer and restenosis

New alpha7 nicotinic agonists in Pharmacia pipeline

Novel PDH activators discovered by AstraZeneca scientists

Novartis acquires majority stake in Idenix

Epix Medical selects EP-2104R for clinical development

Further analyses of Riquent phase III and phase II/III data

Recruitment completed in phase II trial of Metastat in Kaposi's sarcoma

DCF-987 constituent awarded orphan drug status for cystic fibrosis

Further analysis of Lescol LIPS results

Pharmexa applies to begin phase I trial of HER-2 Protein AutoVac product

Amylin submits additional Symlin information to Swiss authorities

IND filed for XL-784

New breast cancer gene discovered

Procyon to acquire Pharmacor

Chronic T-1032 proves beneficial in dogs with heart failure

Cardiovascular effects of MMP inhibitor Ono-4817 discussed at Japanese Circulation Society meeting

Andrographolide analogues a focus of anticancer research at Dr. Reddy's

IND filed for anti-HIV drug candidate AMD-070

ACS news: inhibitors of phosphate transport for use in patients with chronic renal disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...